Reporter
-
August 4, 2023
Researchers discover antibody that neutralizes both RSV and hMPV
Vanderbilt and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus and human metapneumovirus. -
August 3, 2023
Osterman, Wanderer named associate chief medical information officers
Travis Osterman, DO, MS, and Jonathan Wanderer, MD, MPhil, have been named associate chief medical information officers in HealthIT at Vanderbilt University Medical Center. -
August 3, 2023
VUMC nurses give presentations at Fuld National Institute EBP Summit
Vanderbilt nurses gave four podium presentations at the 2023 Fuld National Institute EBP Summit in Columbus, Ohio. -
August 3, 2023
Study finds hallmarks of T cell exhaustion within hours of tumor exposure
Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional. -
August 2, 2023
Personalizing treatment for sinus syndrome
Understanding the inflammatory characteristics of subtypes of chronic rhinosinusitis with polyps should assist with selection of effective therapies, Vanderbilt researchers report. -
August 2, 2023
VUMC receives $28 million to lead national study of COVID-diabetes link
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. -
August 2, 2023
The urgency of research
Griffin Rodgers, MD, director of the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, described the urgency of the nation’s diabetes epidemic July 26 during a symposium of the NIDDK Medical Student Research Program in Diabetes and Obesity hosted by Vanderbilt University.